Feldman B F, Kristensen A T
Department of Biomedical Sciences and Pathobiology, Virginia-Maryland Regional College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, USA.
Vet Clin North Am Small Anim Pract. 1995 Nov;25(6):1231-43. doi: 10.1016/s0195-5616(95)50151-2.
There are two main reasons for blood component therapy: the need for an increase in oxygen-carrying capacity and improved hemostasis. Additionally, blood component therapy is used to increase plasma protein concentrations. Component therapy entails separating whole blood into its cellular and plasma components and administering the appropriate blood component based on the patient's needs. General considerations such as compatibility, defined expectations of benefits, and topics including specific disease screening, preparation of blood components, preparation of blood products for administration, and typing and crossmatching in relation to blood component therapy and its application in companion animal practice are discussed.
一是需要提高携氧能力，二是改善止血功能。此外，血液成分疗法还用于提高血浆蛋白浓度。成分疗法是将全血分离成细胞成分和血浆成分，并根据患者需求给予适当的血液成分。文中讨论了一些一般注意事项，如兼容性、对预期益处的明确期望，以及包括特定疾病筛查、血液成分制备、用于输注的血液制品制备，以及与血液成分疗法及其在伴侣动物临床实践中的应用相关的血型鉴定和交叉配血等主题。
